title: Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes.
abstract: OBJECTIVE
  To determine the prevalence of hypertension, patterns of antihypertensive treatment and level of blood pressure control in adult Thai type 2 diabetic patients who attended diabetes clinics in university and tertiary-care hospitals.
  
  
  METHODS
  A cross-sectional, multi-center, hospital-based diabetes registry of 8884 adults 18 years old and older was carried out from diabetes clinics of 11 tertiary centers. Demographic data, including use of antihypertensive drugs and blood samples were collected and analyzed for prevalence, associated factors, patterns of antihypertensive therapy and level of blood pressure control.
  
  
  RESULTS
  The prevalence of hypertension in adult Thai type 2 diabetic patients was 78.4 (6965)%. Antihypertensive drugs were prescribed in 84.4 (5878)% of all hypertensive patients. The achievement of blood pressure control (less than 130/80 mmHg) w as 13.85%. Thepercentage of patients receiving 1, 2, 3, 4, and 5 drugs were 45 (2645)%, 33.4 (1963)%, 16.8 (987)%, 4.4 (259)%, and 0.4 (24)% respectively. Angiotensin-converting enzyme inhibitors were the most commonly prescribed antihypertensive agents (54.6%), followed by diuretics (43.8%), and calcium channel blockers (34.6%).
  
  
  CONCLUSIONS
  Blood pressure control in hypertensive adults with type 2 diabetes was suboptimal. Strategies to improve awareness and adequacy of blood pressure control in these subjects should be seriously considered.
authors: Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. pongamorn@thaiendocrine.org
authors: Pongamorn
authors: P
authors: Bunnag
authors: Nattachet
authors: N
authors: Plengvidhya
authors: Chaicharn
authors: C
authors: Deerochanawong
authors: Sompongse
authors: S
authors: Suwanwalaikorn
authors: Natapong
authors: N
authors: Kosachunhanun
authors: Yupin
authors: Y
authors: Benjasuratwong
authors: Sirinate
authors: S
authors: Krittiyawong
authors: Rattana
authors: R
authors: Leelawatana
authors: Thongchai
authors: T
authors: Pratipanawatr
authors: Chardpraorn
authors: C
authors: Ngarmukos
authors: Thanya
authors: T
authors: Chetthakul
authors: Gobchai
authors: G
authors: Puavilai
authors: Sirima
authors: S
authors: Mongkolsomlit
authors: Petch
authors: P
authors: Rawdaree
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D003430:Cross-Sectional Studies; D048909:Diabetes Complications; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D016730:Program Development; D012042:Registries; D012307:Risk Factors; D013785:Thailand / Q000453:epidemiology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents